0.33 (3.20%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Strong
Earnings
Very Strong
Earnings
Neutral
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Nuvectis Pharma, Inc.
Telephone
1.201.614.3151
Address
2nd floor, Suite 275, 1 Bridge Plaza, Fort Lee, NJ 07024
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 5.55 - 13.34
Trade Value (12mth)
US$197,374.00
1 week
-6.7%
1 month
20.05%
YTD
21.03%
1 year
2.49%
All time high
20.92
EPS 3 yr Growth
-12.20%
EBITDA Margin
0.00%
Operating Cashflow
-$16m
Free Cash Flow Return
-113.80%
ROIC
-205.30%
Interest Coverage
0.00
Quick Ratio
2.40
Shares Outstanding (Fully Diluted)
23m
HALO Sector
Healthcare
Next Company Report Date
09-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 05 May 26 | |
| 05 May 26 | |
| 20 February 26 | |
| 12 February 26 | |
| 12 February 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -1.43 | -1.11 | -1.32 | | | | ||
EPS (Fully Diluted) | $ | | | | | -1.43 | -1.11 | -1.32 | | | | ||
Growth | % | | | | | 5.1 | 22.4 | -19.2 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
